Mode
Text Size
Log in / Sign up

Digitally augmented intervention increases 6-month abstinence from health-risk behaviors by RR 1.51Text Messages After ER Visit Cut Risky Habits

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider digitally augmented interventions to improve multi-behavior abstinence rates in emergency department settings.

This randomized controlled trial enrolled 572 adults (18-65 years) in a Hong Kong emergency department who engaged in at least one health-risk behavior, including tobacco and alcohol use. Participants were triaged as semi-urgent or non-urgent and had smartphone access. The intervention group received a brief telephone-based AWARD-model intervention followed by weekly WhatsApp or WeChat messages for 6 months. The control group received brief telephone advice only.

At 6 months, the intervention group showed a 30.1% abstinence rate from at least one health-risk behavior compared to 19.9% in the control group (RR=1.51; 95% CI, 1.13-2.02; P=0.006). Additionally, the intervention group showed a greater reduction in the number of risky behaviors at 6 months (RR=1.54; P=0.01) and at 12 months (RR=1.48; P=0.02). Physical inactivity improvement was also higher in the intervention group at 6 months (31.7% vs. 16.2%; P<0.001).

Safety and tolerability data were not reported. The study is limited by its single-center design, reliance on self-reported outcomes, and potential loss to follow-up. While the intervention showed short-term benefits, effects appeared to attenuate after the cessation of booster messaging. Clinical application should consider the limitations of self-reported data and the specific cultural context of the study setting.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in digital intervention strategies for multi-behavior risk reduction. While prior coverage noted that nicotine electronic cigarettes increase quit rates and that early assessment at 4 weeks versus 8 weeks increases abstinence odds in tobacco users, this study specifically evaluates a digitally augmented, theory-based approach for multiple behaviors. It complements existing evidence on behavioral support but focuses on the role of mobile messaging in promoting abstinence.

This randomized trial tested whether a digital health program could help emergency department patients with at least one risky health behavior. The study included 572 adults aged 18 to 65 in Hong Kong who were triaged as semi-urgent or non-urgent and had smartphone access. One group received brief telephone advice only. The other group received a theory-based phone session plus weekly messages on WhatsApp or WeChat for six months.

At six months, 30.1% of the message group reported stopping at least one risky behavior, compared with 19.9% of the advice-only group. The message group also showed greater reductions in the number of risky behaviors at six months and at twelve months. Physical inactivity improved for 31.7% of the message group versus 16.2% of the advice-only group at six months.

The study has important limits. All outcomes were self-reported, so people may have overestimated their progress. It was done at a single hospital in Hong Kong, so results may not apply everywhere. Some participants were lost to follow-up. The benefits also weakened after the weekly messages stopped.

This suggests that ongoing digital support after an ER visit may help some people make healthier choices, but it is not a proven cure and may not work the same way for everyone. Talk with your doctor about the best approach for your situation.

What this means for you:
Weekly texts after an ER visit helped some patients cut risky habits, but benefits faded when messages stopped.

Common questions

How many people did the text message program help?

At six months, 30.1% of people who got the messages reported stopping at least one risky behavior, compared with 19.9% of those who only got brief phone advice. That means about 1 in 3 in the message group saw this benefit, versus about 1 in 5 in the advice-only group.

What kinds of risky behaviors were studied?

The study looked at general health-risk behaviors, including tobacco use and alcohol use. Physical inactivity was also tracked. The program aimed to help people reduce or stop at least one of these behaviors, not necessarily all of them.

Did the benefits last after the messages stopped?

The main benefit was seen at six months, while the weekly messages were still being sent. The study notes that effects weakened after the booster messaging stopped. At twelve months, some reduction in risky behaviors remained, but the short-term advantage was stronger.

Were there any side effects from the program?

The study did not report any side effects, serious adverse events, or dropouts due to the program. The main concerns were about the study design, not safety. Because outcomes were self-reported and the study was done at one hospital, the results should be interpreted with caution.

Who might this program help most?

The study included adults aged 18 to 65 who came to an emergency department with a semi-urgent or non-urgent issue, had at least one risky health behavior, and had smartphone access. It is not clear if the same results would apply to other groups or settings. Ask your doctor if a similar program could be right for you.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up780.0 mo
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Noncommunicable diseases (NCDs) are the leading global cause of death and are driven by modifiable behaviors, such as tobacco use, harmful alcohol consumption, unhealthy diet, and physical inactivity. Recognizing that emergency department (ED) visits represent a unique opportunity to promote behavior change, this trial evaluated a digitally augmented, theory based general health promotion approach, combining a brief telephone-based intervention with mobile instant messaging support, to help discharged ED patients abstain from health risk behaviors. METHODS AND FINDINGS: This assessor-blinded randomized controlled trial was conducted in a major public hospital ED in Hong Kong. Adults (18-65 years) triaged as semi-urgent or non-urgent and with ≥1 health-risk behavior and smartphone access were randomized to receive a digitally augmented, theory‑based general health‑promotion intervention consisting of a brief telephone‑based AWARD‑model intervention (Ask, Warn, Advise, Refer, and Do-it-again) followed by weekly WhatsApp or WeChat messages for 6 months, or to a control group receiving brief telephone advice only. The primary outcome was self-report abstinence from ≥1 health-risk behavior at 6 months; secondary outcomes included the proportion of participants who achieved self-reported abstinence from ≥1 health-risk behavior at 12 months and reduction in the number of behaviors at 6 and 12 months. Of the 2,134 screened patients, 572 were enrolled (286 per group). At 6 months, 30.1% of the intervention participants versus 19.9% of the controls achieved self-reported abstinence (RR = 1.51; 95% CI, 1.13-2.02; P = 0.006). The intervention also significantly increased the likelihood of fewer risky behaviors at 6 (RR = 1.54; P = 0.01) and 12 (RR = 1.48; P = 0.02) months. Physical inactivity showed the greatest improvement at 6 months (31.7% versus 16.2%; P < 0.001). The effects attenuated after cessation of booster messaging. Limitations include reliance on self-reported outcomes, the single-center study design, and loss to follow-up, which may have affected the generalizability of the results. CONCLUSIONS: A digitally augmented, theory-based general health promotion strategy delivered at ED discharge through brief telephone intervention and mobile instant messaging support demonstrated short-term benefits in promoting self-reported abstinence and reducing health-risk behaviors at 6 months. However, the absence of a sustained effect at 12 months suggests that extended support or maintenance strategies may be required to maintain these improvements over time. Multicenter trials with longer follow-up are warranted to evaluate long-term effectiveness. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (Registration No: NCT06077565).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.